ClinicalTrials.Veeva

Menu

Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease

Shire logo

Shire

Status and phase

Completed
Phase 4

Conditions

Kidney Failure, Chronic

Treatments

Drug: Lanthanum carbonate

Study type

Interventional

Funder types

Industry

Identifiers

NCT00160121
SPD405-401

Details and patient eligibility

About

The purpose of this study is to test how well lanthanum carbonate reduces the pre-dialysis level of serum phosphorus in subjects undergoing dialysis due to end stage renal disease and to determine the patient and physician's satisfaction.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with ESRD who currently require treatment for hyperphosphatemia

Exclusion criteria

  • Female patient who is pregnant or lactating
  • Patient has used any investigational product within 30 days of screening

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems